---
title: "Mesothelioma Case Study: Heidi"
description: With combination therapy that included targeted therapy guided by FidoCure® genomic sequencing, Heidi has survived over a year following her initial diagnosis of mesothelioma and is still going strong.
image: https://blog.fidocure.com/hubfs/heidi.jpg
---
[](https://www.fidocure.com/)
- [Veterinarians](https://fidocure.com/for-veterinarians/)
- [Portal Login](https://dvm.fidocure.com/)
- [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet)
- [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
- [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars)
- [Pet Parents](https://fidocure.com/pet-parents/)
- [About Us](https://fidocure.com/about-us/)
- [How it works](https://fidocure.com/how-it-works/)
- [Find a Clinic](https://fidocure.com/find-a-clinic/)
- [Contact Us](https://fidocure.com/contact-us/)
[Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
# Mesothelioma Case Study: Heidi
[Dr. Dorothy Jackson Girimonte](https://blog.fidocure.com/fidocure-blog/author/dr-dorothy-jackson-girimonte)
[Share this blog post on Twitter](https://twitter.com/intent/tweet?text=I+found+this+interesting+blog+post&url=https://blog.fidocure.com/fidocure-blog/mesothelioma-case-study-heidi) [Share this blog post on Facebook](http://www.facebook.com/share.php?u=https://blog.fidocure.com/fidocure-blog/mesothelioma-case-study-heidi) [Share this blog post on LinkedIn](http://www.linkedin.com/shareArticle?mini=true&url=https://blog.fidocure.com/fidocure-blog/mesothelioma-case-study-heidi)
#### With combination therapy that included targeted therapy guided by FidoCure® genomic sequencing, Heidi has survived over a year following her initial diagnosis of mesothelioma and is still going strong.
Heidi Stone, a **12-year-old female spayed Dachshund, was diagnosed with a heart base mass** in November 2020 and was treated with radiation therapy. In January, she developed cardiac tamponade. Surgery was felt to be the only way to prevent recurrent cardiac tamponade secondary to fluid accumulation. She had a subtotal pericardiectomy, and tissue was submitted for histopathology.
Following additional staining, she was ultimately** diagnosed with mesothelioma**. Her biopsy tissue was also submitted for FidoCure® analysis. While awaiting sequencing results, she received one dose of intracavitary Carboplatin to help her pleural effusion.
Genomic analysis revealed alterations of FLT3 and PTPRJ. Based on these results, Heidi was put on a tyrosine kinase inhibitor in February 2021.
[**Read the rest of Heidi's story**](https://fidocu.re/heidi)**.**
#### Dr. Dorothy Jackson Girimonte
Dr. Dorothy Jackson Girimonte DVM, Diplomate ACVIM (Oncology), CVA Board certified in Medical Oncology 2015
## Related Articles
[](https://blog.fidocure.com/fidocure-blog/amelanotic-melanoma-case-study-phinn)
[Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
### [Amelanotic Melanoma Case Study: Phinn](https://blog.fidocure.com/fidocure-blog/amelanotic-melanoma-case-study-phinn)
#### With the help of FidoCure® therapy, Phinn has lived a great quality of life for over 18 months after his initial diagnosis of amelanotic melanoma and is still going...
[Dr. Dorothy Jackson Girimonte](https://blog.fidocure.com/fidocure-blog/author/dr-dorothy-jackson-girimonte)
[Read More](https://blog.fidocure.com/fidocure-blog/amelanotic-melanoma-case-study-phinn)
[](https://blog.fidocure.com/fidocure-blog/transitional-cell-carcinoma-case-study-ruby)
[Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies)
### [Transitional Cell Carcinoma Case Study: Ruby](https://blog.fidocure.com/fidocure-blog/transitional-cell-carcinoma-case-study-ruby)
#### With the help of FidoCure® therapy, Ruby had a great quality of life for 2 years after her initial diagnosis of transitional cell carcinoma.
[Dr. Dorothy Jackson Girimonte](https://blog.fidocure.com/fidocure-blog/author/dr-dorothy-jackson-girimonte)
[Read More](https://blog.fidocure.com/fidocure-blog/transitional-cell-carcinoma-case-study-ruby)
- [How it Works](https://fidocure.com/how-it-works/)
- [FAQ](https://fidocure.com/faq/)
- [Contact Us](https://fidocurestg.wpengine.com/contact-us/)
- [For Vets](https://fidocure.com/for-veterinarians/)
- [About Us](https://fidocure.com/about-us/)
- [Terms of Service](https://fidocure.com/terms-of-service/)
- [Blog](https://blog.fidocure.com/fidocure-blog)
- [Careers](https://fidocure.com/careers/)
- [Privacy Policy](https://fidocure.com/privacy-policy/)
-
-
-
-
**FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy.
© Copyright 2018-2026 One Health Company, All rights reserved
```json
{
"@context" : "https://schema.org",
"@type" : "BlogPosting",
"author" : {
"@type" : "Person",
"name" : "Dr. Dorothy Jackson Girimonte",
"url" : "https://blog.fidocure.com/fidocure-blog/author/dr-dorothy-jackson-girimonte"
},
"dateModified" : "2023-05-06T12:38:53.952Z",
"datePublished" : "2023-05-04T17:11:58.000Z",
"headline" : "Mesothelioma Case Study: Heidi",
"image" : [ "https://blog.fidocure.com/hubfs/heidi.jpg" ],
"mainEntityOfPage" : {
"@id" : "https://blog.fidocure.com/fidocure-blog/mesothelioma-case-study-heidi",
"@type" : "WebPage"
},
"publisher" : {
"@type" : "Organization",
"logo" : {
"@type" : "ImageObject",
"url" : "https://blog.fidocure.com/hubfs/fidocure_logo.png"
},
"name" : "FidoCure"
}
}
```